Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 13,798 | 25,374 | 34,401 | 26,942 | 12,053 |
| Cost of Goods | 838 | 533 | 538 | 599 | 537 |
| Gross Profit | 12,960 | 24,841 | 33,863 | 26,343 | 11,516 |
| Operating Expenses | 44,070 | 63,086 | 59,129 | 56,460 | 45,946 |
| Operating Income | -30,272 | -37,712 | -24,728 | -29,518 | -33,893 |
| Interest Expense | 5,187 | 5,113 | 2,163 | 1,619 | 1,614 |
| Other Income | 910 | 1,005 | 561 | 415 | 448 |
| Pre-tax Income | -34,549 | -41,820 | -26,330 | -30,722 | -35,059 |
| Income Tax | N/A | N/A | -4,009 | N/A | N/A |
| Net Income Continuous | -34,549 | -41,820 | -22,321 | -30,722 | -35,059 |
| Net Income | $-34,549 | $-41,820 | $-22,321 | $-30,722 | $-35,059 |
| EPS Basic Total Ops | -0.33 | -0.40 | -0.22 | -0.29 | -0.33 |
| EPS Basic Continuous Ops | -0.33 | -0.40 | -0.21 | -0.29 | -0.33 |
| EPS Diluted Total Ops | -0.33 | -0.40 | -0.22 | -0.29 | -0.33 |
| EPS Diluted Continuous Ops | -0.33 | -0.40 | -0.21 | -0.29 | -0.33 |
| EBITDA(a) | $-29,059 | $-36,480 | $-23,617 | $-28,437 | $-32,831 |